What: Shares of Ampio Pharmaceuticals, Inc. ( AMPE ), a biopharmaceutical company focused on developing therapies to treat metabolic, eye, kidney, and chronic inflammation diseases, jumped as much as 13% after announcing a $25 million in fresh financing. So what: According to Ampio's press release, it will be selling 4.6 million shares to a limited number of investors (mostly institutional investors), who will be able to purchase Ampio at a substantial discount of $5.50 per share. The gross proceeds will be $25 million, which, after taxes, will practically double the company's existing cash balance of $12.5 million.